One of the main challenges in detecting MRD is the heterogeneity of cancer cells. Variations in the genetic and phenotypic characteristics of cancer cells can make it difficult to identify all residual disease using a single method. Moreover, the sensitivity and specificity of the detection techniques can vary, leading to potential false positives or false negatives.
